590372-17-1 Usage
General Description
2-BROMO-4-(TRIFLUOROMETHYL)QUINOLINE is a chemical compound with the molecular formula C9H5BrF3N. It is a quinoline derivative with a bromine atom at position 2 and a trifluoromethyl group at position 4 of the quinoline ring. 2-BROMO-4-(TRIFLUOROMETHYL)QUINOLINE is commonly used as a building block in the synthesis of pharmaceuticals, agrochemicals, and other organic compounds. It is known for its versatile reactivity and is widely used in medicinal chemistry research for the development of new drugs. Additionally, 2-BROMO-4-(TRIFLUOROMETHYL)QUINOLINE has also been studied for its potential antimicrobial and antifungal properties.
Check Digit Verification of cas no
The CAS Registry Mumber 590372-17-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,9,0,3,7 and 2 respectively; the second part has 2 digits, 1 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 590372-17:
(8*5)+(7*9)+(6*0)+(5*3)+(4*7)+(3*2)+(2*1)+(1*7)=161
161 % 10 = 1
So 590372-17-1 is a valid CAS Registry Number.
InChI:InChI=1/C10H5BrF3N/c11-9-5-7(10(12,13)14)6-3-1-2-4-8(6)15-9/h1-5H
590372-17-1Relevant articles and documents
On the mechanism of the palladium-catalyzed tert-butylhydroperoxide- mediated wacker-type oxidation of alkenes using quinoline-2-oxazoline ligands
Michel, Brian W.,Steffens, Laura D.,Sigman, Matthew S.
supporting information; scheme or table, p. 8317 - 8325 (2011/07/08)
The mechanism of the tert-butylhydroperoxide-mediated, Pd(Quinox)-catalyzed Wacker-type oxidation was investigated to evaluate the hypothesis that a selective catalyst-controlled oxidation could be achieved by rendering the palladium coordinatively saturated using a bidentate amine ligand. The unique role of the Quinox ligand framework was probed via systematic ligand modifications. The modified ligands were evaluated through quantitative Hammett analysis, which supports a push-pull relationship between the electronically asymmetric quinoline and oxazoline ligand modules.
